SCHEMBL891359

SCHEMBL891359

COC(=O)c1ccc2[nH]c(=O)n(CCNC(=O)OC(C)(C)C)c2c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.47
ALDH1A1 P00352 8/20 0.47
GAA P10253 7/20 0.47
HPGD P15428 5/20 0.47
GLA P06280 3/20 0.47
KMT2A Q03164 2/20 0.47
HTT P42858 2/20 0.47
HSD17B10 Q99714 2/20 0.47
PKM P14618 2/20 0.47
BRD4 O60885 1/20 0.44
B3GNT2 Q9NY97 2/20 0.43
TDP1 Q9NUW8 1/20 0.43
DRD2 P14416 1/20 0.41
MAPT P10636 3/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL897551 0.90 B3GNT2 (0.55) KDM4EALDH1A1GAAHPGDGLA
SCHEMBL891295 0.86 DYRK1A (0.49) HSD17B10BRD4DRD2
SCHEMBL15173247 0.84 B3GNT2 (0.53) KDM4EALDH1A1GAAHPGDHSD17B10
SCHEMBL13315300 0.84 KDM4E (0.46) KDM4EALDH1A1GAAHPGDGLA
SCHEMBL891197 0.82 BCHE (0.49) ALDH1A1HPGDKMT2AHTTTDP1
SCHEMBL27760417 0.78 B3GNT2 (0.50) KDM4EALDH1A1GAAHPGDGLA
SCHEMBL20529258 0.78 KMT2A (0.55) KDM4EALDH1A1GAAHPGDGLA
SCHEMBL5171827 0.77 BCHE (0.45) ALDH1A1HPGDKMT2AHTTTDP1
SCHEMBL13011486 0.77 CNR2 (0.56) ALDH1A1HPGDBRD4DRD2
SCHEMBL4915938 0.77 ALDH1A1 (0.47) KDM4EALDH1A1GAAHPGDGLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268273-B1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON PHARMACEUTICALS INC (US) 2017-06-28 EP disclosed
EP-2268273-B1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON PHARMACEUTICALS INC (US) 2017-06-28 EP disclosed
CN-101420942-B Small-molecule modulators of TRP-P8 activity DENDREON CORP 2014-03-12 CN disclosed
US-8618155-B2 Small-molecule modulators of Trp-p8 activity DENDREON CORPORATION (US) 2013-12-31 US disclosed
US-8614243-B2 Small-molecule modulators of Trp-p8 activity DENDREON CORPORATION (US) 2013-12-24 US disclosed
EP-1986622-B1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORP (US) 2013-10-02 EP disclosed
EP-2510925-A2 Small-Molecule modulators of TRP-P8 activity DENDREON CORPORATION (US) 2012-10-17 EP disclosed
US-20120225871-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2012-09-06 US disclosed
US-20120225871-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2012-09-06 US disclosed
US-20120225871-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2012-09-06 US disclosed
WO-2009067410-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2009-05-28 WO disclosed
WO-2009067410-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2009-05-28 WO disclosed
CN-101420942-A Small-molecule modulators of TRP-P8 activity DENDREON CORP (US) 2009-04-29 CN disclosed
US-20080255185-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2008-10-16 US disclosed
US-20080255185-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2008-10-16 US disclosed
US-20080255185-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2008-10-16 US disclosed
US-20070232603-A1 Small-molecule modulators of TRP-P8 activity DENDREON CORPORATION (US) 2007-10-04 US disclosed
US-20070232603-A1 Small-molecule modulators of TRP-P8 activity DENDREON CORPORATION (US) 2007-10-04 US disclosed
US-20070232603-A1 Small-molecule modulators of TRP-P8 activity DENDREON CORPORATION (US) 2007-10-04 US disclosed
WO-2007095340-A2 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY DENDREON CORPORATION (US) 2007-08-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070232603-A1 Small-molecule modulators of TRP-P8 activity TRPC4, TRPC3, TRPC1 KDM4E 3912/4885ALDH1A1 4789/4885GAA 4591/4885
US-20080255185-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY TRPC4, TRPC3, TRPC1 KDM4E 3912/4885ALDH1A1 4789/4885GAA 4591/4885
US-20120225871-A1 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY TRPC4, TRPC3, TRPC1 KDM4E 3912/4885ALDH1A1 4789/4885GAA 4591/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.